NCT07287748 2025-12-31
A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
Alpha Fusion Inc.
Phase 1 Recruiting
Clinical Trials
3 trialsNCT05007093 2024-11-07
Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Peking Union Medical College Hospital
Phase 2 Active not recruiting
NCT06405217 2024-05-08
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
Nanjing First Hospital, Nanjing Medical University
Phase NA Recruiting